about
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysisA gene expression signature predicts survival of patients with stage I non-small cell lung cancerInhibitory effect of fuzheng yiliuyin in combination with chemotherapeutics on human gastric carcinoma cell strainHeat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival.Adjuvant chemoradiotherapy versus chemotherapy for gastric cancer: a meta-analysis of randomized controlled trials.Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells.UBE2T knockdown inhibits gastric cancer progression.Imaging in assessing hepatic and peritoneal metastases of gastric cancer: a systematic review.Mortality differences by surgical volume among patients with stomach cancer: a threshold for a favorable volume-outcome relationshipHonokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signalsGastric cancer, Helicobacter pylori infection and other risk factors.Effect of gastrectomy with bursectomy on prognosis of gastric cancer: a meta-analysisSerpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancerGene expression signature-based prognostic risk score in gastric cancerTetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells.Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study.Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.More controversy than ever - challenges and promises towards personalized treatment of gastric cancerSelecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.Risk factors for No. 12p and No. 12b lymph node metastases in advanced gastric cancer in ChinaInnovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies.Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experienceCharacteristics of gastric cancer recurrence five or more years after curative gastrectomyNon-curative gastric resection for patients with stage 4 gastric cancer--a single center experience and current review of literature.A review of in vitro and in vivo models of oesophageal and gastric cancer.Integrin-linked kinase in gastric cancer cell attachment, invasion and tumor growth.Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of gastric cancer cells.Comparative analysis of the interaction of HSPs in dendritic cells, macrophages, RGM-1 cells infected by Helicobacter pylori.Gastric cancer, nutritional status, and outcome.Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancer.Are biomarkers correlated with recurrence patterns in patients with resectable gastric adenocarcinoma.Is there any long-term benefit in quality of life after laparoscopy-assisted distal gastrectomy for gastric cancer?Non-invasive detection of gastric cancer relevant d-amino acids with luminescent DNA/silver nanoclusters.Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single-institution retrospective analysis of 2163 Chinese patients.Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience.
P2860
Q26738505-F4B1E48A-BC78-4E51-80AE-4C6B2627C2C3Q28764568-AF088EAE-4594-4680-9F5A-6E03A9D41357Q33248449-90BCB3AD-2AC7-4405-901F-178AB2829FE9Q33407026-4CFD187C-9AAA-48E7-82DA-165A2B33AEF7Q33417940-EFE3C922-636A-4FF7-BE98-D30662AD2B97Q33716328-44184A48-10EB-4447-93DF-3DF84F1F143CQ33778535-AF67F7DA-F1B1-4D7A-BEB1-DA996727310CQ33779187-E63DABDE-E31C-42D2-929B-608228462D7DQ33840377-FC493F29-5AA0-4C1D-8EFD-0821E9E05C35Q33909756-C65CE47B-1FD0-4C4D-AF74-86CCB07E696BQ34219578-00893FFD-61C0-422C-9318-3BFAFFDE4CFBQ34390957-D9AC9B6C-5EB1-48F0-9747-A862524EA1C2Q34405219-C1721DC2-6D53-408F-82A7-335EDE86FBBCQ34499645-7F04F6DE-810F-4A41-A35D-CFACFC0BEA07Q34802936-D4F06141-25FD-48C7-B69D-7558422EEEC7Q35009473-9035C299-240F-4407-ACCD-D5A623E06CFCQ35083852-3F58953C-8772-4ECC-A951-AF3DAE18A57FQ36207166-3A9185B5-9DBD-4760-AA90-EE12D3030B83Q36368271-8AE81468-1D83-4A32-8CBF-E8F537FCC6B6Q36374816-FAE97CB6-2C99-4DBE-A17E-F9C5BD6B31E0Q36494032-74F881C2-6F71-447B-AD60-F65DC2D61323Q36500558-42E5C2F7-8F3E-4811-B4EF-1C710B83E88EQ36529266-5ECE95A3-6EE1-427F-913F-AA40C9A8209DQ36610522-CA8D40E8-032B-41D6-8D97-245F4918FB0BQ37035264-8FF70C72-4950-42B3-986F-7332C9E7B93EQ37265612-92D36C23-BE50-47B0-B366-3F8139679FC1Q37402100-5E598BFB-D929-4318-9806-7CA6CFD340D3Q37981607-F14129A0-EE58-4FA5-AAFC-2EE8CB886CF2Q38088347-BA5B7E3C-04FD-4A86-B501-0A8FE277AC6FQ38268065-213E5D6D-DF92-4D6B-B7AF-59C18857A9E6Q39555319-2B026284-DC10-4150-BB82-FEE05A2FD425Q39629842-1FB0A4D7-AF72-4094-9F97-24E38A5B8E0EQ40458007-72A3D128-8B48-4855-8F08-573654110B8EQ41820200-0A38D969-03C2-4CD2-8466-5E1685C6CF38Q42407047-38141A60-E674-42D2-AA5D-3A34F059C319Q43733166-B00745B9-80D2-4163-A2AE-D08DF3A24C99Q45119706-76BDF64B-7F6B-4680-B1F3-50CBE70B039BQ47288838-76853ACD-EF63-40DB-9789-C1CCF6415AC9Q48227570-0BDA3B82-39A5-41A2-8F51-3BE2E25EABF0Q51125872-85FC01B4-219B-45E6-B333-D60491F770EB
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Perspectives in the treatment of gastric cancer.
@ast
Perspectives in the treatment of gastric cancer.
@en
type
label
Perspectives in the treatment of gastric cancer.
@ast
Perspectives in the treatment of gastric cancer.
@en
prefLabel
Perspectives in the treatment of gastric cancer.
@ast
Perspectives in the treatment of gastric cancer.
@en
P356
P1476
Perspectives in the treatment of gastric cancer
@en
P2093
Angelos M Kappas
P304
P356
10.1038/NCPONC0099
P577
2005-02-01T00:00:00Z